All Stories

  1. Cytotoxic Effects of a Triorganotin Derivative on HTLV-1-Infected Cells at Different Immortalization/Transformation Stages In Vitro

    Article • Molecules, January 2026, MDPI AG

    Prof Claudia Matteucci

  2. Expression of HERV-K and embryonic genes in chronic lymphocytic leukemia and their association with therapy regimens

    Article • Blood Advances, August 2025, American Society of Hematology

    Prof Claudia Matteucci

  3. Crosstalk between human endogenous retroviruses and exogenous viruses

    Article • Microbes and Infection, July 2025, Elsevier

    Prof Claudia Matteucci

  4. Bioactive Compounds as Alternative Approaches for Preventing Urinary Tract Infections in the Era of Antibiotic Resistance

    Article • Antibiotics, February 2025, MDPI AG

    Prof Claudia Matteucci

  5. HERVs Endophenotype in Autism Spectrum Disorder: Human Endogenous Retroviruses, Specific Immunoreactivity, and Disease Association in Different Family Members

    Article • Microorganisms, December 2024, MDPI AG

    Prof Claudia Matteucci

  6. Flow cytometry for extracellular vesicle characterization in COVID-19 and post-acute sequelae of SARS-CoV-2 infection

    Article • Extracellular Vesicles and Circulating Nucleic Acids, August 2024, OAE Publishing

    Prof Claudia Matteucci

  7. Preliminary Evidence of the Differential Expression of Human Endogenous Retroviruses in Kawasaki Disease and SARS-CoV-2-Associated Multisystem Inflammatory Syndrome in Children

    Article • International Journal of Molecular Sciences, October 2023, MDPI AG

    Prof Claudia Matteucci

  8. Antioxidant Phytocomplexes Extracted from Pomegranate (Punica granatum L.) Using Hydrodynamic Cavitation Show Potential Anticancer Activity In Vitro

    Article • Antioxidants, August 2023, MDPI AG

    Prof Claudia Matteucci

  9. Antioxidant Phytocomplexes Isolated from Pomegranate (<em>Punica granatum</em> L.) Using Hydrodynamic Cavitation Reveal Potential Application as Adjuvants in Cancer Therapies

    Article • July 2023, MDPI AG

    Prof Claudia Matteucci

  10. Biological Evaluation of Triorganotin Derivatives as Potential Anticancer Agents

    Article • Molecules, May 2023, MDPI AG

    Prof Claudia Matteucci

  11. Thymosin α1 interacts with Galectin-1 modulating the β-galactosides affinity and inducing alteration in the biological activity

    Article • International Immunopharmacology, May 2023, Elsevier

    Prof Claudia Matteucci

  12. Differential Expression of Endogenous Retroviruses and Inflammatory Mediators in Female and Male Offspring in a Mouse Model of Maternal Immune Activation

    Article • International Journal of Molecular Sciences, November 2022, MDPI AG

    Prof Claudia Matteucci

  13. Infection Rate of Respiratory Viruses in the Pandemic SARS-CoV-2 Period Considering Symptomatic Patients: Two Years of Ongoing Observations

    Article • Biomolecules, July 2022, MDPI AG

    Prof Claudia Matteucci

  14. MEOX2 Regulates the Growth and Survival of Glioblastoma Stem Cells by Modulating Genes of the Glycolytic Pathway and Response to Hypoxia

    Article • Cancers, May 2022, MDPI AG

    Prof Claudia Matteucci

  15. High CD169 Monocyte/Lymphocyte Ratio Reflects Immunophenotype Disruption and Oxygen Need in COVID-19 Patients

    Article • Pathogens, December 2021, MDPI AG

    Prof Claudia Matteucci

  16. High CD169 Monocyte/Lymphocyte Ratio Reflects the Immunophenotyping Disruption and Predicts Oxygen Need in COVID-19 Patients

    Article • May 2021, MDPI AG

    Prof Claudia Matteucci

  17. Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients

    Article • EBioMedicine, April 2021, Elsevier

    Prof Claudia Matteucci

  18. Thymosin Alpha 1 Mitigates Cytokine Storm in Blood Cells From Coronavirus Disease 2019 Patients

    Article • Open Forum Infectious Diseases, December 2020, Oxford University Press (OUP)

    Prof Claudia Matteucci

  19. Antiretroviral Therapy in HTLV-1 Infection: An Updated Overview

    Article • Pathogens, May 2020, MDPI AG

    Prof Claudia Matteucci

  20. Endogenous Retroviruses Activity as a Molecular Signature of Neurodevelopmental Disorders

    Article • International Journal of Molecular Sciences, November 2019, MDPI AG

    Prof Claudia Matteucci

  21. The Concomitant Expression of Human Endogenous Retroviruses and Embryonic Genes in Cancer Cells under Microenvironmental Changes is a Potential Target for Antiretroviral Drugs

    Article • Cancer Microenvironment, November 2019, Springer Science + Business Media

    Prof Claudia Matteucci

  22. Human endogenous retroviruses role in cancer cell stemness

    Article • Seminars in Cancer Biology, December 2018, Elsevier

    Prof Claudia Matteucci

  23. The Decrease in Human Endogenous Retrovirus-H Activity Runs in Parallel with Improvement in ADHD Symptoms in Patients Undergoing Methylphenidate Therapy

    Article • International Journal of Molecular Sciences, October 2018, MDPI AG

    Prof Claudia Matteucci

  24. Early Behavioral Alterations and Increased Expression of Endogenous Retroviruses Are Inherited Across Generations in Mice Prenatally Exposed to Valproic Acid

    Article • Molecular Neurobiology, September 2018, Springer Science + Business Media

    Prof Claudia Matteucci

  25. Human Endogenous Retrovirus K in the Crosstalk Between Cancer Cells Microenvironment and Plasticity: A New Perspective for Combination Therapy

    Article • Frontiers in Microbiology, July 2018, Frontiers

    Prof Claudia Matteucci

  26. Deciphering cellular biological processes to clinical application: a new perspective for Tα1 treatment targeting multiple diseases

    Article • Expert Opinion on Biological Therapy, May 2018, Taylor & Francis

    Prof Claudia Matteucci

  27. High expression of Endogenous Retroviruses from intrauterine life to adulthood in two mouse models of Autism Spectrum Disorders

    Article • Scientific Reports, January 2018, Springer Science + Business Media

    Prof Claudia Matteucci

  28. Thymosin alpha 1 and HIV-1: recent advances and future perspectives

    Article • Future Microbiology, February 2017, Future Medicine

    Prof Claudia Matteucci

  29. HERV-K activation is strictly required to sustain CD133+ melanoma cells with stemness features

    Article • Journal of Experimental & Clinical Cancer Research, January 2017, Springer Science + Business Media

    Prof Claudia Matteucci

  30. The EuroSciCon's 2015 Innate Immunity Summit

    Article • Future Virology, October 2016, Future Medicine

    Prof Claudia Matteucci

  31. Abstract C03: Role of human endogenous retrovirus-K in phenotype-switching of metastatic melanoma cells during microenvironment alterations

    Article • Cancer Research, July 2016, American Association for Cancer Research (AACR)

    Prof Claudia Matteucci

  32. Historical review on thymosin α1 in oncology: preclinical and clinical experiences

    Article • Expert Opinion on Biological Therapy, June 2015, Informa Healthcare

    Prof Claudia Matteucci

  33. Thymosin α 1 potentiates the release by CD8+cells of soluble factors able to inhibit HIV-1 and human T lymphotropic virus 1 infectionin vitro

    Article • Expert Opinion on Biological Therapy, June 2015, Informa Healthcare

    Prof Claudia Matteucci

  34. Characterization of the enhanced apoptotic response to azidothymidine by pharmacological inhibition of NF-kB

    Article • Life Sciences, April 2015, Elsevier

    Prof Claudia Matteucci

  35. Transcriptional Activity of Human Endogenous Retroviruses in Human Peripheral Blood Mononuclear Cells

    Article • BioMed Research International, January 2015, Hindawi Publishing Corporation

    Prof Claudia Matteucci

  36. Detection of high levels of S urvivin–immunoglobulin M immune complex in sera from hepatitis C virus infected patients with cirrhosis

    Article • Hepatology Research, December 2013, Wiley

    Prof Claudia Matteucci

  37. Human endogenous retroviruses and ADHD

    Article • The World Journal of Biological Psychiatry, November 2013, Taylor & Francis

    Prof Claudia Matteucci

  38. HERVs Expression in Autism Spectrum Disorders

    Article • PLOS One, November 2012, PLOS

    Prof Claudia Matteucci

  39. Thymosin α1 and cancer: action on immune effector and tumor target cells

    Article • Annals of the New York Academy of Sciences, October 2012, Wiley

    Prof Claudia Matteucci

  40. Retrotransposon-Encoded Reverse Transcriptase in the Genesis, Progression and Cellular Plasticity of Human Cancer

    Article • Cancers, March 2011, MDPI AG

    Dr Corrado Spadafora, Prof Claudia Matteucci

  41. Inhibition of NF-κB activation sensitizes U937 cells to 3′-azido-3′-deoxythymidine induced apoptosis

    Article • Cell Death and Disease, October 2010, Springer Science + Business Media

    Prof Claudia Matteucci

  42. Transcription profile of human lymphocytes following in vitro treatment with thymosin alpha-1

    Article • Annals of the New York Academy of Sciences, May 2010, Wiley

    Prof Claudia Matteucci

  43. The activation of human endogenous retrovirus K (HERV-K) is implicated in melanoma cell malignant transformation

    Article • Experimental Cell Research, March 2009, Elsevier

    Prof Claudia Matteucci

  44. Effector caspase activation, in the absence of a conspicuous apoptosis induction, in mononuclear cells treated with azidothymidine

    Article • Pharmacological Research, February 2009, Elsevier

    Prof Claudia Matteucci

  45. Activation of human endogenous retrovirus K (HERV-K) and cellular modifications in human melanoma cell line: transcriptional profiling analysis

    Article • Retrovirology, January 2009, Springer Science + Business Media

    Prof Claudia Matteucci

  46. Effect of Phosphonated Carbocyclic 2′-Oxa-3′-Aza-Nucleoside on Human T-Cell Leukemia Virus Type 1 Infection In Vitro

    Article • Antimicrobial Agents and Chemotherapy, October 2007, ASM Journals

    Prof Claudia Matteucci

  47. Thymosin Alpha 1: From Bench to Bedside

    Article • Annals of the New York Academy of Sciences, May 2007, Wiley

    Prof Claudia Matteucci

  48. Apoptotic Cell Signaling in Lymphocytes from HIV+ Patients during Successful Therapy

    Article • Annals of the New York Academy of Sciences, December 2006, Wiley

    Prof Claudia Matteucci

  49. Activation of human endogenous retrovirus-K and production of infectious viral-like particles in human melanoma cells

    Article • Melanoma Research, September 2006, Wolters Kluwer Health

    Prof Claudia Matteucci

  50. Apoptosis-associated gene expression in HIV-infected patients in response to successful antiretroviral therapy

    Article • Journal of Medical Virology, January 2006, Wiley

    Prof Claudia Matteucci

  51. Modulation of apoptosis during HTLV-1-mediated immortalization process in vitro

    Article • Journal of Medical Virology, January 2004, Wiley

    Prof Claudia Matteucci

  52. Thymosin α1 in combination with cytokines and chemotherapy for the treatment of cancer

    Article • International Immunopharmacology, August 2003, Elsevier

    Prof Claudia Matteucci

  53. Effect of Lamivudine on Transmission of Human T-Cell Lymphotropic Virus Type 1 to Adult Peripheral Blood Mononuclear Cells In Vitro

    Article • Antimicrobial Agents and Chemotherapy, September 2002, ASM Journals

    Prof Claudia Matteucci

  54. Defective Fas ligand production in lymphocytes from MS patients

    Article • Neuroreport, December 2001, Wolters Kluwer Health

    Claudia Caltagirone, Prof Claudia Matteucci

  55. Efficacy of 3′-azido 3′deoxythymidine (AZT) in preventing HTLV-1 transmission to human cord blood mononuclear cells

    Article • Virus Research, November 2001, Elsevier

    Prof Claudia Matteucci

  56. NGF-withdrawal induces apoptosis in pancreatic beta cells in vitro

    Article • Diabetologia, October 2001, Springer Science + Business Media

    Prof Claudia Matteucci

  57. Changes in apoptosis after interruption of potent antiretroviral therapy in patients with maximal HIV-1-RNA suppression

    Article • AIDS, June 2001, Wolters Kluwer Health

    Prof Claudia Matteucci

  58. Impaired apoptosis in mitogen-stimulated lymphocytes of patients with multiple sclerosis

    Article • Neuroreport, February 1999, Wolters Kluwer Health

    Claudia Caltagirone, Prof Claudia Matteucci

  59. Identification of nuclei from apoptotic, necrotic, and viable lymphoid cells by using multiparameter flow cytometry

    Article • Cytometry Part A, February 1999, Wiley

    Prof Claudia Matteucci

  60. Human Th1 and Th2 T-cell clones are equally susceptible to infection and immortalization by human T-lymphotropic virus type I.

    Article • Journal of General Virology, October 1998, Society for General Microbiology

    Prof Claudia Matteucci

  61. Immunological and endocrinological disturbances in patients after prolonged coma following head injury

    Article • European Journal of Neurology, March 1998, Wiley

    Prof Claudia Matteucci

  62. Interleukin 4 stimulates infection and temporary growth of human neonatal lymphocytes exposed in vitro to human T-lymphotropic virus type I, but fails to substitute for interleukin 2 in the immortalization of infected cultures.

    Article • Journal of General Virology, October 1997, Society for General Microbiology

    Prof Claudia Matteucci

  63. Immunological Events during the Early Phase of Infection with Schistosoma Mansoni in Mice

    Article • International Journal of Immunopathology and Pharmacology, September 1997, SAGE Publications

    Prof Claudia Matteucci